Two Chinese biotech firms drop US listing plans, tap HK for $800m floats

Two Chinese biotech firms drop US listing plans, tap HK for $800m floats

Photo: Pixabay

Julie Zhu, Fiona Lau

26 April, 2018

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter

Read more from Greater China

Nikkei Logo
DealStreetAsia Logo
About Us
Team
Advertise
Contact
Careers
Blog
Privacy Policy
Terms & Conditions
© Copyright DEALSTREETASIA 2014-2025 All rights reserved.